NeuroBo Pharmaceuticals, Inc
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRBO and other ETFs, options, and stocks.About NRBO
NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases.
CEOHyung-Heon Kim
CEOHyung-Heon Kim
Employees8
Employees8
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2014
Founded2014
Employees8
Employees8
NRBO Key Statistics
Market cap16.93M
Market cap16.93M
Price-Earnings ratio-1.41
Price-Earnings ratio-1.41
Dividend yield—
Dividend yield—
Average volume26.11K
Average volume26.11K
High today$3.59
High today$3.59
Low today$3.35
Low today$3.35
Open price$3.59
Open price$3.59
Volume22.65K
Volume22.65K
52 Week high$6.75
52 Week high$6.75
52 Week low$2.89
52 Week low$2.89